Novel NMDA receptor modulators: an update

Author： Santangelo Rose M   Acker Timothy M   Zimmerman Sommer S   Katzman Brooke M   Strong Katie L   Traynelis Stephen F   Liotta Dennis C  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.11, 2012-11, pp. : 1337-1352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational NMDA receptor modulators for depression

By Szewczyk Bernadeta   Pałłucha-Poniewiera Agnieszka   Poleszak Ewa   Pilc Andrzej   Nowak Gabriel  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

By Singh Surendra P.   Singh Vidhi  

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 859-885

Adis International

Access to resources Recommend Favorite

Recent advances in the development of novel glucocorticoid receptor modulators

By Berlin Michael  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 855-873

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Discovery of Novel Glucocorticoid Receptor Modulators

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-04 ,pp. : 521-530

Bentham Science Publishers

Access to resources Recommend Favorite

Novel prostaglandin receptor modulators – Part II: EP receptor modulators; a patent review (2002 – 2012)

By Flesch Daniel   Merk Daniel   Lamers Christina   Schubert-Zsilavecz Manfred  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 233-267

Informa Healthcare

Access to resources Recommend Favorite